Impact of Prolonged Anticoagulation with Rivaroxaban on Provoked Venous Thromboembolism Recurrence: IMPROVE-VTE

Coleman, Craig I.; Turpie, Alexander G.G.; Bunz, Thomas J; Beyer-Westendorf, Jan; Baker, William L

doi:10.1016/j.amjmed.2018.11.040

Record: found
Abstract: not found
Article: not found

Impact of Prolonged Anticoagulation with Rivaroxaban on Provoked Venous Thromboembolism Recurrence: IMPROVE-VTE

Author(s): Craig I. Coleman , Alexander G.G. Turpie , Thomas J. Bunz , Jan Beyer-Westendorf , William L. Baker

Publication date Created: December 2018

Publication date (Print): December 2018

Journal: The American Journal of Medicine

Publisher: Elsevier BV

Read this article at

ScienceOpenPublisher PubMed

Bookmark

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

We sought to evaluate the real-world effectiveness and safety of prolonged anticoagulation with rivaroxaban following a provoked venous thromboembolism.

Related collections

Author and article information

Journal

Title: The American Journal of Medicine

Abbreviated Title: The American Journal of Medicine

Publisher: Elsevier BV

ISSN (Print): 00029343

Publication date Created: December 2018

Publication date (Print): December 2018

Article

DOI: 10.1016/j.amjmed.2018.11.040

PubMed ID: 30582894

SO-VID: 0bd5816b-2560-4a7b-b1e7-a1f18644471e

License:

https://www.elsevier.com/tdm/userlicense/1.0/

History

Data availability:

Comments

Comment on this article

scite_

Cited by 2

See all cited by

- Version 1

Impact of Prolonged Anticoagulation with Rivaroxaban on Provoked Venous Thromboembolism Recurrence: IMPROVE-VTE

Read this article at

Abstract

Related collections

Microbiology Society

Author and article information

Journal

Article

History

Comments

Comment on this article

Similar content 2,754

Cited by 2